Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 18364505)

1.

Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.

Lester J, Pahouja G, Andersen B, Lustberg M.

J Pers Med. 2015 Mar 25;5(2):50-66. doi: 10.3390/jpm5020050.

2.

Caring for the breast cancer survivor's health and well-being.

Casey PM, Faubion SS, MacLaughlin KL, Long ME, Pruthi S.

World J Clin Oncol. 2014 Oct 10;5(4):693-704. doi: 10.5306/wjco.v5.i4.693. Review.

3.

Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.

Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S.

Breast Cancer Res Treat. 2014 Jun;145(2):371-9. doi: 10.1007/s10549-014-2930-x. Epub 2014 Apr 10.

4.

Breast cancer in women using digoxin: tumor characteristics and relapse risk.

Biggar RJ, Andersen EW, Kroman N, Wohlfahrt J, Melbye M.

Breast Cancer Res. 2013 Feb 19;15(1):R13. doi: 10.1186/bcr3386.

5.

The 2012 hormone therapy position statement of: The North American Menopause Society.

North American Menopause Society.

Menopause. 2012 Mar;19(3):257-71. doi: 10.1097/gme.0b013e31824b970a.

6.

Gynecologic care for breast cancer survivors: assisting in the transition to wellness.

Salani R, Andersen BL.

Am J Obstet Gynecol. 2012 May;206(5):390-7. doi: 10.1016/j.ajog.2011.10.858. Epub 2011 Oct 21. Review.

7.

Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions.

Chen WY.

Endocrinol Metab Clin North Am. 2011 Sep;40(3):509-18, viii. doi: 10.1016/j.ecl.2011.05.006. Epub 2011 Jul 12. Review.

8.

Challenges in the gynecologic care of premenopausal women with breast cancer.

Bakkum-Gamez JN, Laughlin SK, Jensen JR, Akogyeram CO, Pruthi S.

Mayo Clin Proc. 2011 Mar;86(3):229-40. doi: 10.4065/mcp.2010.0794. Epub 2011 Feb 9. Review. Erratum in: Mayo Clin Proc. 2011 Apr;86(4):364.

9.

Nonhormonal management of hot flashes for women on risk reduction therapy.

Sideras K, Loprinzi CL.

J Natl Compr Canc Netw. 2010 Oct;8(10):1171-9.

10.

Climacteric Complaints after Breast Cancer - Is HRT an Option?

Singer CF.

Breast Care (Basel). 2008;3(3):204-209. Epub 2008 Jun 20.

11.

Breast cancer in young women and its impact on reproductive function.

Hickey M, Peate M, Saunders CM, Friedlander M.

Hum Reprod Update. 2009 May-Jun;15(3):323-39. doi: 10.1093/humupd/dmn064. Epub 2009 Jan 27. Review.

12.

Exogenous and endogenous hormones and breast cancer.

Chen WY.

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):573-85. doi: 10.1016/j.beem.2008.08.001. Review.

13.
14.

Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.

Horwitz KB, Sartorius CA.

J Clin Endocrinol Metab. 2008 Sep;93(9):3295-8. doi: 10.1210/jc.2008-0938. Epub 2008 Jul 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk